首页 > 最新文献

European Journal of Pharmaceutical Sciences最新文献

英文 中文
Membrane interaction studies of isoniazid derivatives active against drug-resistant tuberculosis 对抗药性结核病有活性的异烟肼衍生物的膜相互作用研究。
IF 4.3 3区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2025-02-01 DOI: 10.1016/j.ejps.2024.106986
Joana F.P.R. Terreiro, Joaquim T. Marquês, Inês Antunes, Catarina Frazão de Faria, Susana Santos, Filomena Martins, Rodrigo F.M. de Almeida
Tuberculosis is one of the leading causes of mortality worldwide due to the growth of multi-drug resistant strains unsusceptible to currently available therapies. Four compounds, isoniazid (INH) and three derivatives, N'-decanoylisonicotinohydrazide (INHC10), N'-(E)-(4-phenoxybenzylidene)isonicotinohydrazide (N34) and N’-(4-phenoxybenzyl)isonicotinohydrazide (N34red), were studied. Owing to their advantageous in vitro selectivity index against the primary mutation responsible for drug resistance in Mycobacterium tuberculosis (Mtb), as well as their suitable lipophilicity and interaction with human serum albumin, INHC10 and N34 were deemed promising antitubercular compounds. N34red, despite differing from N34 only in the saturation of the N′ = C bond, presents a poor selectivity index. To delve deeper into the therapeutic potential of these compounds, their interaction with biomembrane models, mimicking biological barriers on the way to the target inside Mtb cells, was herein evaluated. All compounds, except N34red, weakened the packing of the acyl chains in the rigid lipid gel phase, especially INHC10, which was the only compound disturbing liquid disordered membranes. Notably, all compounds except INH decreased membrane dipole potential, across all types of bilayers studied, but only N34red had a drastic effect. The insertion in gel phase bilayers suggests that the compounds may be able to penetrate the rigid cell wall of Mtb. Förster's resonance energy transfer (FRET) assays in ternary bilayers with liquid ordered/liquid disordered lateral heterogeneity mimicking human cell membranes, showed that the compounds affected neither the size nor the organization of lipid domains. These results provide molecular insights into the low toxicity against human cell lines and improved activity against drug-resistant Mtb of INHC10 and N34.
结核病是世界范围内死亡的主要原因之一,原因是多种耐药菌株的增长对现有疗法不敏感。研究了异烟肼(INH)及其衍生物N′-癸烷基异烟碱肼(INH- c10)、N′-(E)-(4-苯氧苄基)异烟碱肼(N34)和N′-(4-苯氧苄基)异烟碱肼(N34red)。由于INH-C10和N34对结核分枝杆菌(Mtb)耐药的主要突变具有良好的体外选择性指数,并且具有合适的亲脂性和与人血清白蛋白的相互作用,因此被认为是有前景的抗结核化合物。N34red与N34的区别仅在于N′ = 键的饱和度,但其选择性指数较差。为了更深入地研究这些化合物的治疗潜力,本文评估了它们与生物膜模型的相互作用,模拟了结核分枝杆菌细胞内通往靶标的生物屏障。除N34red外,所有化合物都削弱了刚性脂质凝胶相中酰基链的堆积,尤其是INH-C10,它是唯一干扰液体无序膜的化合物。值得注意的是,除了INH外,所有化合物都降低了所有类型双分子层的膜偶极电势,但只有N34red有明显的影响。在凝胶相双分子层中的插入表明,这些化合物可能能够穿透结核分枝杆菌坚硬的细胞壁。Förster的共振能量转移(FRET)实验表明,在模拟人细胞膜的液有序/液无序横向异质性的三元双层中,化合物既不影响脂质结构域的大小,也不影响脂质结构域的组织。这些结果为INH-C10和N34对人类细胞系的低毒性和提高对耐药Mtb的活性提供了分子见解。
{"title":"Membrane interaction studies of isoniazid derivatives active against drug-resistant tuberculosis","authors":"Joana F.P.R. Terreiro,&nbsp;Joaquim T. Marquês,&nbsp;Inês Antunes,&nbsp;Catarina Frazão de Faria,&nbsp;Susana Santos,&nbsp;Filomena Martins,&nbsp;Rodrigo F.M. de Almeida","doi":"10.1016/j.ejps.2024.106986","DOIUrl":"10.1016/j.ejps.2024.106986","url":null,"abstract":"<div><div>Tuberculosis is one of the leading causes of mortality worldwide due to the growth of multi-drug resistant strains unsusceptible to currently available therapies. Four compounds, isoniazid (INH) and three derivatives, <em>N</em>'-decanoylisonicotinohydrazide (INH<img>C10), <em>N</em>'-(<em>E</em>)-(4-phenoxybenzylidene)isonicotinohydrazide (N34) and <em>N</em>’-(4-phenoxybenzyl)isonicotinohydrazide (N34red), were studied. Owing to their advantageous <em>in vitro</em> selectivity index against the primary mutation responsible for drug resistance in <em>Mycobacterium tuberculosis</em> (<em>Mtb</em>), as well as their suitable lipophilicity and interaction with human serum albumin, INH<img>C10 and N34 were deemed promising antitubercular compounds. N34red, despite differing from N34 only in the saturation of the <em>N</em>′ = C bond, presents a poor selectivity index. To delve deeper into the therapeutic potential of these compounds, their interaction with biomembrane models, mimicking biological barriers on the way to the target inside <em>Mtb</em> cells, was herein evaluated. All compounds, except N34red, weakened the packing of the acyl chains in the rigid lipid gel phase, especially INH<img>C10, which was the only compound disturbing liquid disordered membranes. Notably, all compounds except INH decreased membrane dipole potential, across all types of bilayers studied, but only N34red had a drastic effect. The insertion in gel phase bilayers suggests that the compounds may be able to penetrate the rigid cell wall of <em>Mtb</em>. Förster's resonance energy transfer (FRET) assays in ternary bilayers with liquid ordered/liquid disordered lateral heterogeneity mimicking human cell membranes, showed that the compounds affected neither the size nor the organization of lipid domains. These results provide molecular insights into the low toxicity against human cell lines and improved activity against drug-resistant <em>Mtb</em> of INH<img>C10 and N34.</div></div>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":"205 ","pages":"Article 106986"},"PeriodicalIF":4.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142823788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Small-scale aqueous suspension preparation using dual centrifugation: the effect of process parameters on the sizes of drug particles 双离心制备小型水悬浮液:工艺参数对药物颗粒大小的影响。
IF 4.3 3区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2025-02-01 DOI: 10.1016/j.ejps.2024.106980
Nadina Zulbeari, Nanna Einshøj Lund, René Holm
The dual centrifugation approach has in the recent years emerged as a powerful milling tool to prepare pharmaceutical suspensions in submicron range with a fast-milling capacity by milling 40 samples simultaneously in 2 mL vials. While there is some standardized milling conditions described in the literature when preparing aqueous suspensions with dual centrifugation, a more systematic and experimental understanding of the milling process to evaluate the impact of different process variables in the dual centrifuge on the final sizes of the suspended drug particles independent of the drug compound used was desired. Overall, the present study demonstrated the applicability of the dual centrifuge for small-scale screening purposes and showed the impact of process parameters on the physical attributes of prepared suspensions. In the present work, the rate of size reduction on three different model compounds, i.e., cinnarizine, haloperidol, and indomethacin, was found to be mostly influenced by the milling speed, size of milling beads, and the bead loading during milling, whereas the rotor temperature did not affect the particle size profiles when stabilized with polysorbate 20 during milling with dual centrifugation. Smaller particle sizes were in general obtained at the highest milling intensity, i.e., 1500 rpm, smallest bead size, i.e., 0.2 mm, and higher bead loadings (42 %, 56 %, and 83 %). The grinding limit of approximately 0.50 µm, 0.70 µm, and 0.35 µm for cinnarizine, haloperidol, and indomethacin, respectively, was achieved relatively fast, i.e., 30 min of milling at the specified conditions, compared to when suspensions were milled with larger bead sizes (i.e., 1.0 mm), lower milling intensities (e.g., 1000 rpm), and lower bead loadings (e.g., 14 or 28 %). The study further confirmed that a higher milling intensity was necessary during milling of haloperidol suspensions probably due to the compounds predominantly plastic properties. Sizes of indomethacin particles increased with longer milling runs up to 240 min and also higher bead loadings of 56 % and 83 %. These observations were further supported by the color conversion from white to yellow of indomethacin suspensions which indicated generation of small quantities of amorphic material after milling with a high milling intensity. Upscale investigations showed comparable particle size profiles for all three model compounds while milling at 1500 rpm for five minutes.
近年来,双离心方法已成为一种强大的研磨工具,用于制备亚微米范围内的药物悬浮液,具有快速研磨能力,可同时在2ml小瓶中研磨40个样品。虽然文献中描述了双离心制备水悬浮液时的一些标准化研磨条件,但对研磨过程的更系统和实验的理解,以评估双离心机中不同工艺变量对悬浮药物颗粒最终尺寸的影响,而不依赖于所使用的药物化合物。总的来说,本研究证明了双离心机在小规模筛选中的适用性,并显示了工艺参数对制备悬浮液物理属性的影响。本研究发现,肉桂碱、氟哌啶醇和吲哚美辛三种不同模型化合物的粒径减小速率主要受磨粒速度、磨粒尺寸和磨粒载荷的影响,而双离心磨粒过程中用聚山梨酯20稳定时,转子温度对粒径分布没有影响。在最高的研磨强度(即1500 rpm)下,通常可以获得较小的颗粒尺寸,最小的珠粒尺寸(即0.2 mm)和较高的珠粒负载(42%,56%和83%)。肉桂嗪、氟哌啶醇和吲哚美辛的研磨极限分别约为0.50µm、0.70µm和0.35µm,相对较快,即在规定条件下研磨30分钟,与研磨较大粒径(即1.0 mm)、较低研磨强度(例如1000 rpm)和较低研磨量(例如14%或28%)的悬浮液相比。研究进一步证实,在氟哌啶醇悬浮液的铣削过程中需要更高的铣削强度,这可能是由于化合物主要具有塑性性质。随着磨矿时间的延长(240分钟),吲哚美辛颗粒的粒径也增加了,粉粒负荷也增加了56%和83%。吲哚美辛悬浮液的颜色由白色变为黄色进一步支持了这些观察结果,这表明在高研磨强度下研磨后产生了少量非晶物质。高档调查显示,在1500转/分磨磨5分钟时,所有三种模型化合物的粒度分布相当。
{"title":"Small-scale aqueous suspension preparation using dual centrifugation: the effect of process parameters on the sizes of drug particles","authors":"Nadina Zulbeari,&nbsp;Nanna Einshøj Lund,&nbsp;René Holm","doi":"10.1016/j.ejps.2024.106980","DOIUrl":"10.1016/j.ejps.2024.106980","url":null,"abstract":"<div><div>The dual centrifugation approach has in the recent years emerged as a powerful milling tool to prepare pharmaceutical suspensions in submicron range with a fast-milling capacity by milling 40 samples simultaneously in 2 mL vials. While there is some standardized milling conditions described in the literature when preparing aqueous suspensions with dual centrifugation, a more systematic and experimental understanding of the milling process to evaluate the impact of different process variables in the dual centrifuge on the final sizes of the suspended drug particles independent of the drug compound used was desired. Overall, the present study demonstrated the applicability of the dual centrifuge for small-scale screening purposes and showed the impact of process parameters on the physical attributes of prepared suspensions. In the present work, the rate of size reduction on three different model compounds, <em>i.e.,</em> cinnarizine, haloperidol, and indomethacin, was found to be mostly influenced by the milling speed, size of milling beads, and the bead loading during milling, whereas the rotor temperature did not affect the particle size profiles when stabilized with polysorbate 20 during milling with dual centrifugation. Smaller particle sizes were in general obtained at the highest milling intensity, <em>i.e.,</em> 1500 rpm, smallest bead size, <em>i.e.,</em> 0.2 mm, and higher bead loadings (42 %, 56 %, and 83 %). The grinding limit of approximately 0.50 µm, 0.70 µm, and 0.35 µm for cinnarizine, haloperidol, and indomethacin, respectively, was achieved relatively fast, <em>i.e.,</em> 30 min of milling at the specified conditions, compared to when suspensions were milled with larger bead sizes (<em>i.e.,</em> 1.0 mm), lower milling intensities (<em>e.g.,</em> 1000 rpm), and lower bead loadings (<em>e.g.,</em> 14 or 28 %). The study further confirmed that a higher milling intensity was necessary during milling of haloperidol suspensions probably due to the compounds predominantly plastic properties. Sizes of indomethacin particles increased with longer milling runs up to 240 min and also higher bead loadings of 56 % and 83 %. These observations were further supported by the color conversion from white to yellow of indomethacin suspensions which indicated generation of small quantities of amorphic material after milling with a high milling intensity. Upscale investigations showed comparable particle size profiles for all three model compounds while milling at 1500 rpm for five minutes.</div></div>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":"205 ","pages":"Article 106980"},"PeriodicalIF":4.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142791304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protein aggregation in the frozen state induced by dropping stress 下降应激诱导冰冻状态下的蛋白质聚集。
IF 4.3 3区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2025-02-01 DOI: 10.1016/j.ejps.2024.106996
Tetsuo Torisu , Ayuko Maeda , Shuhei Ito , Susumu Uchiyama
The formation of protein aggregates, which can be immunogenic and lower the efficacy and safety of protein drugs, has been an issue in biopharmaceutical development for more than a decade. Although protein drugs are often shipped as frozen material, the effect of the accidental dropping of frozen proteins, which can occur during shipping and handling, on the physical stability has not been studied. Here, a frozen Fc fusion protein was subjected to dropping stress and the increase in the aggregate concentration was evaluated. Significant increases in micron-sized aggregates were observed at –30 °C (p ≤ 0.01), but not at –60 °C. Proteins adsorbed on the vial surfaces were not remarkably detached by the action of dropping and were not the primary cause of the increase in micron-sized aggregates. When the vials were dropped, local heat generation occurred and this led to local freeze-thaw stress that induced protein aggregation. Poloxamer-188, which is known to mitigate aggregation caused by freeze-thaw stress, effectively prevented the aggregation caused by the dropping stress in the frozen state at –30 °C. In addition, rapid freezing could suppress the aggregation caused by the dropping stress. The results demonstrated that dropping stress reduced the stability of proteins even in the frozen state, and they provide new insights into the formulation and freezing processes to prevent protein aggregation caused by dropping stress in the frozen state.
蛋白质聚集体的形成可能具有免疫原性,降低蛋白质药物的有效性和安全性,这是十多年来生物制药开发中的一个问题。虽然蛋白质药物通常以冷冻材料运输,但在运输和处理过程中可能发生的冷冻蛋白质意外掉落对其物理稳定性的影响尚未研究。在这里,冷冻的Fc融合蛋白受到下降应力,并评估聚集体浓度的增加。在-30°C时,微米级聚集体显著增加(p≤0.01),而在-60°C时则无显著增加。吸附在小瓶表面的蛋白质并没有因滴下作用而显著分离,也不是微米级聚集体增加的主要原因。当小瓶掉落时,局部产生热量,这导致局部冻融应力,诱导蛋白质聚集。Poloxamer-188具有减轻冻融应力引起的聚集的作用,在-30℃的冻结状态下,有效地阻止了下降应力引起的聚集。此外,速冻还能抑制由落应力引起的凝集。结果表明,即使在冷冻状态下,下降应力也会降低蛋白质的稳定性,这为防止在冷冻状态下下降应力引起的蛋白质聚集的配方和冷冻过程提供了新的见解。
{"title":"Protein aggregation in the frozen state induced by dropping stress","authors":"Tetsuo Torisu ,&nbsp;Ayuko Maeda ,&nbsp;Shuhei Ito ,&nbsp;Susumu Uchiyama","doi":"10.1016/j.ejps.2024.106996","DOIUrl":"10.1016/j.ejps.2024.106996","url":null,"abstract":"<div><div>The formation of protein aggregates, which can be immunogenic and lower the efficacy and safety of protein drugs, has been an issue in biopharmaceutical development for more than a decade. Although protein drugs are often shipped as frozen material, the effect of the accidental dropping of frozen proteins, which can occur during shipping and handling, on the physical stability has not been studied. Here, a frozen Fc fusion protein was subjected to dropping stress and the increase in the aggregate concentration was evaluated. Significant increases in micron-sized aggregates were observed at –30 °C (<em>p</em> ≤ 0.01), but not at –60 °C. Proteins adsorbed on the vial surfaces were not remarkably detached by the action of dropping and were not the primary cause of the increase in micron-sized aggregates. When the vials were dropped, local heat generation occurred and this led to local freeze-thaw stress that induced protein aggregation. Poloxamer-188, which is known to mitigate aggregation caused by freeze-thaw stress, effectively prevented the aggregation caused by the dropping stress in the frozen state at –30 °C. In addition, rapid freezing could suppress the aggregation caused by the dropping stress. The results demonstrated that dropping stress reduced the stability of proteins even in the frozen state, and they provide new insights into the formulation and freezing processes to prevent protein aggregation caused by dropping stress in the frozen state.</div></div>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":"205 ","pages":"Article 106996"},"PeriodicalIF":4.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142893253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FT-NIR models for predicting film quality parameters in titanium dioxide-free tablet coatings 预测无二氧化钛片剂包衣膜质量参数的FT-NIR模型。
IF 4.3 3区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2025-02-01 DOI: 10.1016/j.ejps.2024.106992
Filip Gorachinov , Monika Koviloska , Katerina Tnokovska , Ana Atanasova , Packa Antovska , Jelena Lazova , Nikola Geskovski
This study leverages Fourier Transform Near-Infrared (FT-NIR) spectroscopy to monitor the coating process of pharmaceutical tablets using PVA-based TiO2-free films, with talc and iron oxides as opacifiers. By employing a combination of multivariate analytical techniques, the correlation between film coating progression and film thickness was evaluated. Assessment of coating thickness for different coating levels was performed by optical microscopy. Additionally, using colorimetric analysis by scanner method, the color progression for different coating levels was evaluated and expressed as the a* value from CIELAB color space. The coordinate value a* showed predictable changes with the progression of the coating process and film thickness values, indicating its utility as a robust reference method for quality control and process optimization. The predictive capability of the OPLS models, validated against measured film thickness and the a* value, demonstrated low prediction errors and confirmed the models' effectiveness in distinguishing coating levels and accurately predicting film coating progression. The OPLS model used knowledge-based peaks of interest, which were further confirmed by loading and coefficient plots. The study demonstrated that film thickness, as a destructive, and a* value from CIELAB color space, as a non-destructive reference method for coating progression could be used during a controlled pharmaceutical coating process for product quality assessment and pharmaceutical process endpoint determination.
本研究利用傅里叶变换近红外(FT-NIR)光谱技术,以滑石粉和氧化铁作为不透明剂,监测pva基无tio2薄膜药物片剂的包覆过程。采用多元分析技术的组合来评价膜层进展与膜层厚度之间的相关性。通过光学显微镜对不同涂层水平的涂层厚度进行评估。此外,采用扫描仪比色分析方法,评估了不同涂层水平的颜色级数,并将其表示为CIELAB色彩空间的a*值。座标值a*随涂层工艺和膜厚值的变化具有可预测性,可作为质量控制和工艺优化的可靠参考方法。根据实测膜厚和a*值验证了ops模型的预测能力,显示出较低的预测误差,并证实了该模型在区分涂层水平和准确预测薄膜涂层进展方面的有效性。ops模型使用基于知识的兴趣峰,并通过加载图和系数图进一步证实。研究表明,薄膜厚度作为一种破坏性指标,与CIELAB色彩空间中的*值作为涂层进度的一种非破坏性参考方法,可用于受控药物涂层过程中产品质量评价和制药过程终点确定。
{"title":"FT-NIR models for predicting film quality parameters in titanium dioxide-free tablet coatings","authors":"Filip Gorachinov ,&nbsp;Monika Koviloska ,&nbsp;Katerina Tnokovska ,&nbsp;Ana Atanasova ,&nbsp;Packa Antovska ,&nbsp;Jelena Lazova ,&nbsp;Nikola Geskovski","doi":"10.1016/j.ejps.2024.106992","DOIUrl":"10.1016/j.ejps.2024.106992","url":null,"abstract":"<div><div>This study leverages Fourier Transform Near-Infrared (FT-NIR) spectroscopy to monitor the coating process of pharmaceutical tablets using PVA-based TiO<sub>2</sub>-free films, with talc and iron oxides as opacifiers. By employing a combination of multivariate analytical techniques, the correlation between film coating progression and film thickness was evaluated. Assessment of coating thickness for different coating levels was performed by optical microscopy. Additionally, using colorimetric analysis by scanner method, the color progression for different coating levels was evaluated and expressed as the a* value from CIELAB color space. The coordinate value a* showed predictable changes with the progression of the coating process and film thickness values, indicating its utility as a robust reference method for quality control and process optimization. The predictive capability of the OPLS models, validated against measured film thickness and the a* value, demonstrated low prediction errors and confirmed the models' effectiveness in distinguishing coating levels and accurately predicting film coating progression. The OPLS model used knowledge-based peaks of interest, which were further confirmed by loading and coefficient plots. The study demonstrated that film thickness, as a destructive, and a* value from CIELAB color space, as a non-destructive reference method for coating progression could be used during a controlled pharmaceutical coating process for product quality assessment and pharmaceutical process endpoint determination.</div></div>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":"205 ","pages":"Article 106992"},"PeriodicalIF":4.3,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142853390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From extractables to exposure data: Sensitivity analysis of extrapolation algorithms with focus on USP 〈665〉
IF 4.3 3区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-27 DOI: 10.1016/j.ejps.2025.107026
Armin Hauk , Alexander Wildschütz , Ina Pahl , Daniel Canton , Roberto Menzel
We evaluated algorithms designed to extrapolate extractables data for predicting process equipment-related leachables (PERLs) and assessing PERL exposure in single-use systems (SUSs) and assemblies. The robustness and sensitivity of these algorithms were tested against variations in input data, including extrapolation algorithms for both short and long contact time extractables data obtained from the standardized extractables protocol provided in USP 〈665〉. Our findings demonstrate that extrapolated data for SUS and assemblies are suitable for safety assessments. Extrapolated and aggregated data do not systematically underestimate potential PERL exposure values, provided that the extractables data originate from experiments with a higher surface area to contact liquid volume ratio and/or a low liquid to material volume ratio compared to the use scenario. The algorithms are non-sensitive to deviations in input data, as these deviations are propagated decreasingly into extrapolated data and parameters. The quality and significance of PERL exposure calculations can be enhanced by incorporating extractables study data from experiments using a semipolar organic solution, such as ethanol.
{"title":"From extractables to exposure data: Sensitivity analysis of extrapolation algorithms with focus on USP 〈665〉","authors":"Armin Hauk ,&nbsp;Alexander Wildschütz ,&nbsp;Ina Pahl ,&nbsp;Daniel Canton ,&nbsp;Roberto Menzel","doi":"10.1016/j.ejps.2025.107026","DOIUrl":"10.1016/j.ejps.2025.107026","url":null,"abstract":"<div><div>We evaluated algorithms designed to extrapolate extractables data for predicting process equipment-related leachables (PERLs) and assessing PERL exposure in single-use systems (SUSs) and assemblies. The robustness and sensitivity of these algorithms were tested against variations in input data, including extrapolation algorithms for both short and long contact time extractables data obtained from the standardized extractables protocol provided in USP 〈665〉. Our findings demonstrate that extrapolated data for SUS and assemblies are suitable for safety assessments. Extrapolated and aggregated data do not systematically underestimate potential PERL exposure values, provided that the extractables data originate from experiments with a higher surface area to contact liquid volume ratio and/or a low liquid to material volume ratio compared to the use scenario. The algorithms are non-sensitive to deviations in input data, as these deviations are propagated decreasingly into extrapolated data and parameters. The quality and significance of PERL exposure calculations can be enhanced by incorporating extractables study data from experiments using a semipolar organic solution, such as ethanol.</div></div>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":"207 ","pages":"Article 107026"},"PeriodicalIF":4.3,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143046026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human organotypic colon in vitro microtissue: unveiling a new window into colonic drug disposition. 人体器官型结肠体外微组织:揭开结肠药物处置的新窗口。
IF 4.3 3区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-24 DOI: 10.1016/j.ejps.2025.107025
Pedro G M Canhão, Jan Snoeys, Suzy Geerinckx, Marjolein van Heerden, An Van den Bergh, Camden Holm, Jan Markus, Seyoum Ayehunie, Mario Monshouwer, Raymond Evers, Patrick Augustijns, Stephanie Kourula

The purpose of this study was to evaluate EpiColon, a novel human organotypic 3D colon microtissue prototype, developed to assess colonic drug disposition, with a particular focus on permeability ranking, and compare its performance to Caco-2 monolayers. EpiColon was characterized for barrier function using transepithelial electrical resistance (TEER), morphology via histology and immunohistochemistry, and functionality through drug transport studies measuring apparent permeability (Papp). Cutoff thresholds for the permeability of FITC-dextran 4 kDa (FD4), FITC-dextran 10 kDa (FD10S), and [14C]mannitol were established to monitor microtissue integrity. Permeability of EpiColon for 20 benchmark drugs was compared with Caco-2 data, and the activity of pivotal efflux transporters, including multidrug resistance protein 1/P-glycoprotein (MDR1/P-gp), along with multidrug resistance protein 2 (MRP2) and breast cancer resistance protein (BCRP), was evaluated using selective substrates. EpiColon exhibited a physiological barrier function (272.0 ± 53.05 Ω x cm2) and effectively discriminated between high (e.g., budesonide and [3H]metoprolol) and low permeable compounds (e.g., [3H]atenolol and [14C]mannitol). The model demonstrated functional activity for key efflux transporters, with efflux ratios of 2.32 for [3H]digoxin (MDR1/P-gp) and 3.34 for sulfasalazine (MRP2 and BCRP). Notably, EpiColon showed an enhanced dynamic range in the low permeability range, differentiating Papp between FD4 and FD10S, in contrast to Caco-2 monolayers. Significant positive correlations were observed between human fraction absorbed (fabs) and logarithmically transformed Papp [AP-BL] values for both EpiColon (rs = 0.68) and Caco-2 (rs = 0.68). Furthermore, EpiColon recapitulates some essential phenotypic and cellular features of the human colon, including the expression of critical marker genes (Pan-Cytokeratin+: epithelial/colonocytes, Vimentin+: mesenchymal/fibroblast, and Alcian Blue+: goblet cell/mucus). In conclusion, EpiColon is a promising platform that offers a valuable complement to conventional Caco-2 monolayers for studying colonic drug disposition. However, the presence of flat and some cuboidal cells, along with low throughput, must be addressed to improve its applicability in both academic research and pharmaceutical industry.

{"title":"Human organotypic colon in vitro microtissue: unveiling a new window into colonic drug disposition.","authors":"Pedro G M Canhão, Jan Snoeys, Suzy Geerinckx, Marjolein van Heerden, An Van den Bergh, Camden Holm, Jan Markus, Seyoum Ayehunie, Mario Monshouwer, Raymond Evers, Patrick Augustijns, Stephanie Kourula","doi":"10.1016/j.ejps.2025.107025","DOIUrl":"https://doi.org/10.1016/j.ejps.2025.107025","url":null,"abstract":"<p><p>The purpose of this study was to evaluate EpiColon, a novel human organotypic 3D colon microtissue prototype, developed to assess colonic drug disposition, with a particular focus on permeability ranking, and compare its performance to Caco-2 monolayers. EpiColon was characterized for barrier function using transepithelial electrical resistance (TEER), morphology via histology and immunohistochemistry, and functionality through drug transport studies measuring apparent permeability (P<sub>app</sub>). Cutoff thresholds for the permeability of FITC-dextran 4 kDa (FD4), FITC-dextran 10 kDa (FD10S), and [<sup>14</sup>C]mannitol were established to monitor microtissue integrity. Permeability of EpiColon for 20 benchmark drugs was compared with Caco-2 data, and the activity of pivotal efflux transporters, including multidrug resistance protein 1/P-glycoprotein (MDR1/P-gp), along with multidrug resistance protein 2 (MRP2) and breast cancer resistance protein (BCRP), was evaluated using selective substrates. EpiColon exhibited a physiological barrier function (272.0 ± 53.05 Ω x cm<sup>2</sup>) and effectively discriminated between high (e.g., budesonide and [<sup>3</sup>H]metoprolol) and low permeable compounds (e.g., [<sup>3</sup>H]atenolol and [<sup>14</sup>C]mannitol). The model demonstrated functional activity for key efflux transporters, with efflux ratios of 2.32 for [<sup>3</sup>H]digoxin (MDR1/P-gp) and 3.34 for sulfasalazine (MRP2 and BCRP). Notably, EpiColon showed an enhanced dynamic range in the low permeability range, differentiating P<sub>app</sub> between FD4 and FD10S, in contrast to Caco-2 monolayers. Significant positive correlations were observed between human fraction absorbed (f<sub>abs</sub>) and logarithmically transformed P<sub>app</sub> [AP-BL] values for both EpiColon (r<sub>s</sub> = 0.68) and Caco-2 (r<sub>s</sub> = 0.68). Furthermore, EpiColon recapitulates some essential phenotypic and cellular features of the human colon, including the expression of critical marker genes (Pan-Cytokeratin<sup>+</sup>: epithelial/colonocytes, Vimentin<sup>+</sup>: mesenchymal/fibroblast, and Alcian Blue<sup>+</sup>: goblet cell/mucus). In conclusion, EpiColon is a promising platform that offers a valuable complement to conventional Caco-2 monolayers for studying colonic drug disposition. However, the presence of flat and some cuboidal cells, along with low throughput, must be addressed to improve its applicability in both academic research and pharmaceutical industry.</p>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":" ","pages":"107025"},"PeriodicalIF":4.3,"publicationDate":"2025-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143046028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound-assisted efficient targeting of doxorubicin to the tumor microenvironment by lyso-thermosensitive liposomes of varying phase transition temperatures
IF 4.3 3区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-23 DOI: 10.1016/j.ejps.2025.107024
Seyedeh Maryam Hosseinikhah , Leila Farhoudi , Farshad Mirzavi , Fatemeh Vahdat-Lasemi , Leila Arabi , Fatemeh Gheybi , Ameneh Sazgarnia , Seyedeh Hoda Alavizadeh , Mahmoud Reza Jaafari
Premature drug release is the primary hindrance to the effective function of the lyso-thermosensitive liposomes (LTSLs) of doxorubicin (Dox), known as ThermoDox® for the treatment of cancer. Herein, we have optimized LTSLs by using a combination of phospholipids (PLs) with high transition temperatures (Tm) to improve the therapeutic outcome in an assisted ultrasound approach. For this, several Dox LTSLs were prepared using the remote loading method at varying molar ratios (0 to 90 %) of DPPC (Tm 41 °C) and HSPC (Tm 54.5 °C), as well as a constant molar ratio of MSPC (10 %), DSPE-mPEG2000 (4 %). The treatment efficacy was explored by using ultrasound as external hyperthermia (HT) (40–42℃) in mice bearing C26 murine colon carcinoma. All the formulations had an average diameter of around 110 nm, PDI ≤ 0.15, zeta potential of around -12 mV, and Dox encapsulation of >90 %. The cytotoxicity results indicated a higher IC50 value of Dox-LTSLs compared to the ThermoDox® (F0: DPPC:MSPC:DSPE-mPEG2000, 90:10:4), attributed to the faster Dox release in F0 formulation devoid of HSPC. Among various formulations, F25 (DPPC: MSPC: DSPE-mPEG2000: HSPC, 65:10:4:25) showed the highest cellular uptake at 42℃ and significantly improved the antitumor and survival efficacy in mice bearing C26 colon carcinoma in combination with ultrasonic HT compared to F0. Collectively, results demonstrated that optimizing the rigidity of the liposomal bilayers through the combinatorial selection of PLs of different transition temperatures could improve the plasma stability of the liposome, and hence ameliorate the outcome of therapy in assistance with an effective HT approach.
{"title":"Ultrasound-assisted efficient targeting of doxorubicin to the tumor microenvironment by lyso-thermosensitive liposomes of varying phase transition temperatures","authors":"Seyedeh Maryam Hosseinikhah ,&nbsp;Leila Farhoudi ,&nbsp;Farshad Mirzavi ,&nbsp;Fatemeh Vahdat-Lasemi ,&nbsp;Leila Arabi ,&nbsp;Fatemeh Gheybi ,&nbsp;Ameneh Sazgarnia ,&nbsp;Seyedeh Hoda Alavizadeh ,&nbsp;Mahmoud Reza Jaafari","doi":"10.1016/j.ejps.2025.107024","DOIUrl":"10.1016/j.ejps.2025.107024","url":null,"abstract":"<div><div>Premature drug release is the primary hindrance to the effective function of the lyso-thermosensitive liposomes (LTSLs) of doxorubicin (Dox), known as ThermoDox® for the treatment of cancer. Herein, we have optimized LTSLs by using a combination of phospholipids (PLs) with high transition temperatures (Tm) to improve the therapeutic outcome in an assisted ultrasound approach. For this, several Dox LTSLs were prepared using the remote loading method at varying molar ratios (0 to 90 %) of DPPC (Tm 41 °C) and HSPC (Tm 54.5 °C), as well as a constant molar ratio of MSPC (10 %), DSPE-mPEG<sub>2000</sub> (4 %). The treatment efficacy was explored by using ultrasound as external hyperthermia (HT) (40–42℃) in mice bearing C26 murine colon carcinoma. All the formulations had an average diameter of around 110 nm, PDI ≤ 0.15, zeta potential of around -12 mV, and Dox encapsulation of &gt;90 %. The cytotoxicity results indicated a higher IC<sub>50</sub> value of Dox-LTSLs compared to the ThermoDox® (F0: DPPC:MSPC:DSPE-mPEG<sub>2000</sub>, 90:10:4), attributed to the faster Dox release in F0 formulation devoid of HSPC. Among various formulations, F25 (DPPC: MSPC: DSPE-mPEG<sub>2000</sub>: HSPC, 65:10:4:25) showed the highest cellular uptake at 42℃ and significantly improved the antitumor and survival efficacy in mice bearing C26 colon carcinoma in combination with ultrasonic HT compared to F0. Collectively, results demonstrated that optimizing the rigidity of the liposomal bilayers through the combinatorial selection of PLs of different transition temperatures could improve the plasma stability of the liposome, and hence ameliorate the outcome of therapy in assistance with an effective HT approach.</div></div>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":"206 ","pages":"Article 107024"},"PeriodicalIF":4.3,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143037653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of disintegrants on rheological properties and printability in SSE 3D printing of immediate-release formulations
IF 4.3 3区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-21 DOI: 10.1016/j.ejps.2025.107017
Morenikeji Aina , Darya Kuznyetsova , Fabien Baillon , Romain Sescousse , Noelia M. Sanchez-Ballester , Sylvie Begu , Ian Soulairol , Martial Sauceau
This study investigates the effects of disintegrants sodium starch glycolate (SSG) and crospovidone (CP) on the printability, rheological properties, and disintegration time of agar and hydroxypropyl methylcellulose (HPMC)-based formulations designed for semi-solid extrusion. Printability was assessed by measuring the dimensional accuracy of manually extruded filaments. Rheological analysis was performed using oscillatory measurements. Principal component analysis (PCA) and Spearman correlation analysis identified three key components (phase angle, critical strain, and elastic modulus) that explained the total variance in the rheological dataset. A 2 × 32 factorial design was employed to evaluate the impact of CP, SSG, and HPMC on these rheological parameters, as well as on printability and disintegration time. Results indicated that formulations containing HPMC and SSG generally exhibited better printability. Formulations containing CP achieved satisfactory printability only when SSG or HPMC was included. The optimal printability and rheological properties were achieved with formulations containing 5 % CP and 10 % SSG. Linear regression models correlated geometric volumes of the model and pycnometric volumes of printed objects, with validation showing that predicted masses were within a 95 % confidence interval of measured values for various shapes. All formulations demonstrated immediate-release properties, confirming the successful fabrication of personalised immediate-release dosage forms using semi-solid extrusion technology.
{"title":"Impact of disintegrants on rheological properties and printability in SSE 3D printing of immediate-release formulations","authors":"Morenikeji Aina ,&nbsp;Darya Kuznyetsova ,&nbsp;Fabien Baillon ,&nbsp;Romain Sescousse ,&nbsp;Noelia M. Sanchez-Ballester ,&nbsp;Sylvie Begu ,&nbsp;Ian Soulairol ,&nbsp;Martial Sauceau","doi":"10.1016/j.ejps.2025.107017","DOIUrl":"10.1016/j.ejps.2025.107017","url":null,"abstract":"<div><div>This study investigates the effects of disintegrants sodium starch glycolate (SSG) and crospovidone (CP) on the printability, rheological properties, and disintegration time of agar and hydroxypropyl methylcellulose (HPMC)-based formulations designed for semi-solid extrusion. Printability was assessed by measuring the dimensional accuracy of manually extruded filaments. Rheological analysis was performed using oscillatory measurements. Principal component analysis (PCA) and Spearman correlation analysis identified three key components (phase angle, critical strain, and elastic modulus) that explained the total variance in the rheological dataset. A 2 × 3<span><math><msup><mrow></mrow><mrow><mn>2</mn></mrow></msup></math></span> factorial design was employed to evaluate the impact of CP, SSG, and HPMC on these rheological parameters, as well as on printability and disintegration time. Results indicated that formulations containing HPMC and SSG generally exhibited better printability. Formulations containing CP achieved satisfactory printability only when SSG or HPMC was included. The optimal printability and rheological properties were achieved with formulations containing 5 % CP and 10 % SSG. Linear regression models correlated geometric volumes of the model and pycnometric volumes of printed objects, with validation showing that predicted masses were within a 95 % confidence interval of measured values for various shapes. All formulations demonstrated immediate-release properties, confirming the successful fabrication of personalised immediate-release dosage forms using semi-solid extrusion technology.</div></div>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":"206 ","pages":"Article 107017"},"PeriodicalIF":4.3,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143028134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A new population pharmacokinetic model for dosing optimization of zonisamide in patients with refractory epilepsy
IF 4.3 3区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-21 DOI: 10.1016/j.ejps.2025.107023
Rui Silva , Helena Colom , Anabela Almeida , Joana Bicker , Andreia Carona , Ana Silva , Francisco Sales , Isabel Santana , Amílcar Falcão , Ana Fortuna
Zonisamide exhibits significant pharmacokinetic variability, demanding for the development of population pharmacokinetic (PopPK) models to identify key factors influencing drug disposition.
This study aimed to develop and validate a PopPK model to optimize zonisamide posology in patients with refractory epilepsy.
A total of 114 plasma concentrations of zonisamide, obtained from 64 patients, were used for PopPK model development, employing the nonlinear mixed-effects modelling approach. The final model was evaluated by visually inspecting the goodness-of-fit plots and the visual predictive check plot and by the bootstrap resampling method. A one-compartment model with first-order elimination was the one that best described the pharmacokinetic profile of zonisamide. Between-patient variability (BPV) was included on clearance (CL/F), volume of distribution (Vd/F) and absorption rate constant (ka). The residual error (RE) was modeled as proportional. The final model estimates for CL/F, Vd/F and ka were 0.761 L/h, 48.10 L and 0.671 h⁻¹, respectively. The BPV associated with CL/F, Vd/F, and ka was 43.93%, 52.06%, and 91.27%, respectively, while the proportional RE was 7.18%. The concomitant administration of enzyme-inducing antiseizure drugs (EIASDs), included in the model as inducer drug load (INDDL), significantly accounted for BPV associated with CL/F and led to increased CL/F in patients receiving EIASDs compared to the others. Consequently, patients receiving EIASDs require higher daily doses of zonisamide to achieve therapeutic plasma concentrations compared to those not treated with EIASDs.
Model validation, using bootstrap and visual predictive checks, confirmed its stability and robustness, making it a valuable tool for individualized zonisamide dosing in adults with refractory epilepsy.
{"title":"A new population pharmacokinetic model for dosing optimization of zonisamide in patients with refractory epilepsy","authors":"Rui Silva ,&nbsp;Helena Colom ,&nbsp;Anabela Almeida ,&nbsp;Joana Bicker ,&nbsp;Andreia Carona ,&nbsp;Ana Silva ,&nbsp;Francisco Sales ,&nbsp;Isabel Santana ,&nbsp;Amílcar Falcão ,&nbsp;Ana Fortuna","doi":"10.1016/j.ejps.2025.107023","DOIUrl":"10.1016/j.ejps.2025.107023","url":null,"abstract":"<div><div>Zonisamide exhibits significant pharmacokinetic variability, demanding for the development of population pharmacokinetic (PopPK) models to identify key factors influencing drug disposition.</div><div>This study aimed to develop and validate a PopPK model to optimize zonisamide posology in patients with refractory epilepsy.</div><div>A total of 114 plasma concentrations of zonisamide, obtained from 64 patients, were used for PopPK model development, employing the nonlinear mixed-effects modelling approach. The final model was evaluated by visually inspecting the goodness-of-fit plots and the visual predictive check plot and by the bootstrap resampling method. A one-compartment model with first-order elimination was the one that best described the pharmacokinetic profile of zonisamide. Between-patient variability (BPV) was included on clearance (CL/F), volume of distribution (Vd/F) and absorption rate constant (ka). The residual error (RE) was modeled as proportional. The final model estimates for CL/F, Vd/F and ka were 0.761 L/h, 48.10 L and 0.671 h⁻¹, respectively. The BPV associated with CL/F, Vd/F, and ka was 43.93%, 52.06%, and 91.27%, respectively, while the proportional RE was 7.18%. The concomitant administration of enzyme-inducing antiseizure drugs (EIASDs), included in the model as inducer drug load (INDDL), significantly accounted for BPV associated with CL/F and led to increased CL/F in patients receiving EIASDs compared to the others. Consequently, patients receiving EIASDs require higher daily doses of zonisamide to achieve therapeutic plasma concentrations compared to those not treated with EIASDs.</div><div>Model validation, using bootstrap and visual predictive checks, confirmed its stability and robustness, making it a valuable tool for individualized zonisamide dosing in adults with refractory epilepsy.</div></div>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":"207 ","pages":"Article 107023"},"PeriodicalIF":4.3,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143028212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantifying crystallinity of amlodipine maleate in amorphous solid dispersions produced by fluidized bed granulation using PAT tools 利用PAT工具定量定量流化床造粒生产的马来酸氨氯地平非晶态固体分散体的结晶度。
IF 4.3 3区 医学 Q1 PHARMACOLOGY & PHARMACY Pub Date : 2025-01-17 DOI: 10.1016/j.ejps.2025.107018
Sandi Svetič , Laura Medved , Franc Vrečer , Klemen Korasa
One of the main concerns with formulations containing amorphous solid dispersions (ASDs) is their physical stability. Stability can be compromised if a formulation contains any residual crystallinity of an active pharmaceutical ingredient (API) that could act as seeds for further crystallisation. This study presents four methods for crystalline amlodipine maleate quantification in ASD, which were developed using one Raman and three NIR process analysers. A preliminary analysis revealed distinct differences between amorphous and non-amorphous forms of the API, both in the API alone and in the formulation. These differences laid the foundation for model development in subsequent steps. The development of four partial least squares (PLS) models proceeded through two stages, initially using a single granulation batch dataset for training, and then expanding to include three batches. Their predictability was evaluated on an additional batch dataset. Models were evaluated primarily using root mean square error of prediction (RMSEP), residual prediction deviation (RPD), and limit of detection along with other metrics. To the best of authors’ knowledge, this is the first study that focuses on process monitoring of fluidized bed granulation used in preparation of ASD. The results of this study and their interpretations present novel aspects of Raman and NIR process analyser applications in combination with PLS.
对于含有非晶固体分散体(ASDs)的配方,主要关注的问题之一是它们的物理稳定性。如果配方中含有活性药物成分(API)的残余结晶度,可能会影响稳定性,从而成为进一步结晶的种子。本研究建立了4种ASD中马来酸氨氯地平晶体定量方法,分别采用1台拉曼光谱仪和3台近红外光谱仪。初步分析显示,在原料药的非晶态和非晶态形式之间存在明显差异,无论是在原料药本身还是在配方中。这些差异为后续步骤的模型开发奠定了基础。四个偏最小二乘(PLS)模型的开发经历了两个阶段,最初使用单个颗粒批数据集进行训练,然后扩展到包括三个批次。它们的可预测性是在一个额外的批处理数据集上评估的。评估模型主要使用预测均方根误差(RMSEP)、残差预测偏差(RPD)和检出限以及其他指标。据作者所知,这是第一个专注于ASD制备中流化床造粒过程监测的研究。本研究的结果及其解释提出了拉曼和近红外过程分析仪与PLS结合应用的新方面。
{"title":"Quantifying crystallinity of amlodipine maleate in amorphous solid dispersions produced by fluidized bed granulation using PAT tools","authors":"Sandi Svetič ,&nbsp;Laura Medved ,&nbsp;Franc Vrečer ,&nbsp;Klemen Korasa","doi":"10.1016/j.ejps.2025.107018","DOIUrl":"10.1016/j.ejps.2025.107018","url":null,"abstract":"<div><div>One of the main concerns with formulations containing amorphous solid dispersions (ASDs) is their physical stability. Stability can be compromised if a formulation contains any residual crystallinity of an active pharmaceutical ingredient (API) that could act as seeds for further crystallisation. This study presents four methods for crystalline amlodipine maleate quantification in ASD, which were developed using one Raman and three NIR process analysers. A preliminary analysis revealed distinct differences between amorphous and non-amorphous forms of the API, both in the API alone and in the formulation. These differences laid the foundation for model development in subsequent steps. The development of four partial least squares (PLS) models proceeded through two stages, initially using a single granulation batch dataset for training, and then expanding to include three batches. Their predictability was evaluated on an additional batch dataset. Models were evaluated primarily using root mean square error of prediction (RMSEP), residual prediction deviation (RPD), and limit of detection along with other metrics. To the best of authors’ knowledge, this is the first study that focuses on process monitoring of fluidized bed granulation used in preparation of ASD. The results of this study and their interpretations present novel aspects of Raman and NIR process analyser applications in combination with PLS.</div></div>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":"206 ","pages":"Article 107018"},"PeriodicalIF":4.3,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143002521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Journal of Pharmaceutical Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1